Adaptimmune Therapeutics Plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Adaptimmune Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Adaptimmune Therapeutics Plc - ADR
Rating: 0.88833325
Author: Trendlyne DVM scores

about

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

0.06 -0.01 (-14.29%)

95.45% Fall from 52W High

40.2M

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.3 / 100

Technically Bearish

19.2 / 100

1Yr Price target upside is 1033%

3 analysts

Adaptimmune Therapeutics P... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptimmune Therapeutics Plc - ADR Live Stock Price Today, Share Analysis and Chart

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

95.45% Fall from 52W High

SWOT Analysis

Adaptimmune Therapeutics P... Live Price Chart